Imunon (IMNN) director granted 5,557 shares in lieu of board fees
Rhea-AI Filing Summary
Imunon, Inc. director Christine A. Pellizzari received a grant of company common stock as part of her board compensation. She was awarded 5,557 shares of common stock, valued at $2.20 per share, in lieu of a portion of her cash board fees. Following this grant, she directly holds 8,142 shares of Imunon common stock. This is a compensation-related, not open-market, acquisition of shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,557 shares
Net Buy
1 txn
Insider
Pellizzari Christine A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,557 | $2.20 | $12K |
Holdings After Transaction:
Common Stock — 8,142 shares (Direct)
Footnotes (1)
- F1. Stock granted in lieu of cash for portion of board fees
Key Figures
Shares granted: 5,557 shares
Grant valuation price: $2.20 per share
Shares held after grant: 8,142 shares
3 metrics
Shares granted
5,557 shares
Common Stock award on May 22, 2026
Grant valuation price
$2.20 per share
Reported value for stock grant
Shares held after grant
8,142 shares
Direct holdings following the transaction
Key Terms
Common Stock, Grant, award, or other acquisition, in lieu of cash, Form 4
4 terms
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
in lieu of cash financial
"Stock granted in lieu of cash for portion of board fees"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Imunon (IMNN) report for Christine Pellizzari?
Imunon reported that director Christine A. Pellizzari received a grant of 5,557 shares of common stock. The shares were awarded as part of her board compensation rather than bought on the open market.
Was the Imunon (IMNN) stock grant to Christine Pellizzari a market purchase?
No, the transaction was not a market purchase. The filing notes the stock was granted in lieu of cash for a portion of her board fees, making it compensation rather than an open-market buy.
What does the Form 4 stock grant mean for Imunon (IMNN) director compensation?
The Form 4 shows part of director Christine Pellizzari’s board fees paid in stock instead of cash. This structure aligns director compensation more closely with shareholder interests by increasing her equity stake in the company.